Fudan Zhangjiang (01349.HK) will adjust the drug price of the anticancer drug Hydrochloride Pemetrexed Liposome Injection on its nanotechnology platform.

Zhtng Cijng APP news, Fudan Zhangjiang (01349.HK) announced that the group's nanotechnology platform anti-tumor drug Doxorubicin Hydrochloride Liposome for Injection (brand name: Ribavirin) was launched for sales in August 2009. It is the first generic drug of Caelyx in China and the first generic drug of a nano-medicine both domestically and internationally. This drug is a new formulation of Doxorubicin using advanced stealth liposome technology, with passive targeting properties. It is a replacement product for anthracycline drugs, offering advantages in improving efficacy, reducing cardiac toxicity, bone marrow suppression, and minimizing hair loss in cancer treatment. This drug is mainly used for Kaposi's sarcoma associated with AIDS, and can also be used for the treatment of multiple myeloma, breast cancer, and ovarian cancer.